Cargando…
Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations
BACKGROUND: Lipoprotein glomerulopathy (LPG) is a rare kidney disease caused by APOE mutations. The aim of this study was to correlate the genetic and clinical features of LPG. METHODS: Totally eight LPG patients were recruited in this study and Sanger sequencing of APOE was performed for all availa...
Autores principales: | Yang, Mingxin, Weng, Qinjie, Pan, Xiaoxia, Hussain, Hafiz Muhammad Jafar, Yu, Shuwen, Xu, Jing, Yu, Xialian, Liu, Yunzi, Jin, Yuanmeng, Zhang, Chunli, Li, Xiao, Ren, Hong, Chen, Nan, Xie, Jingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434605/ https://www.ncbi.nlm.nih.gov/pubmed/32441489 http://dx.doi.org/10.1002/mgg3.1281 |
Ejemplares similares
-
New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease
por: Weng, Qinjie, et al.
Publicado: (2020) -
Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis
por: Hussain, Hafiz Muhammad Jafar, et al.
Publicado: (2022) -
Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
por: Wu, Hongyan, et al.
Publicado: (2021) -
COL4A3 Mutation Induced Podocyte Apoptosis by Dysregulation of NADPH Oxidase 4 and MMP-2
por: Tong, Jun, et al.
Publicado: (2023) -
Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report
por: Li, Yunsi, et al.
Publicado: (2022)